By Wendy Van Sickle
Columbus, Ohio, Dec. 7 – GS Finance Corp. priced $1.36 million of 0% autocallable underlier-linked notes due Dec. 8, 2022 based on the performance of the S&P 500 index and the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Goldman Sachs Group, Inc.
The notes will be automatically called at par plus an 11.1% annualized call premium if both components close at or above their initial levels on any annual call observation date.
If the notes are not called and both components finish at or above their initial levels, the payout at maturity will be $1,555 per $1,000 principal amount.
If both components finish below their initial levels but the return of each component is at least negative 40%, the payout will be $1,100 per $1,000 note.
If the return of either component is less than negative 40%, the payout will be par plus the return of the lesser performing component, with full exposure to losses.
Goldman, Sachs & Co. is the agent.
Issuer: | GS Finance Corp.
|
Guarantor: | Goldman Sachs Group, Inc.
|
Issue: | Autocallable underlier-linked notes
|
Underlying components: | S&P 500 index, SPDR S&P Biotech ETF
|
Amount: | $1.36 million
|
Maturity: | Dec. 8, 2022
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | If both components finish at or above their initial levels, $1,555 per $1,000 note; if both components finish below their initial levels but the return of each component is at least negative 40%, $1,100 per $1,000 note; if return of either component is less than negative 40%, par plus the return of the lesser performing component, with full exposure to losses
|
Call: | At par plus 11.1% annual call premium if both components close at or above their initial levels on an annual call observation date
|
Initial levels: | 2,642.22 for index, $83.42 for ETF
|
Pricing date: | Dec. 1
|
Settlement date: | Dec. 8
|
Agent: | Goldman, Sachs & Co.
|
Fees: | 2.85%
|
Cusip: | 40055A4X2
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.